The Pharmaceutical Market: Slovenia

Opportunities and Challenges

Publication Date	September 2009
Publisher	Espicom
Product Type	Report
Pages	72
ISBN Number	not applicable
Product Code	ESP00290

Buy this product or for assistance call +44 20 7060 7474

PDF £595.00$990 | €666

FAX Order above formats by FAX

Summary

Slovenia has a sizeable domestic industry and is home to the two largest generics companies in Europe, Krka and Lek. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. In addition to the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.

Includes 3 quarterly updated outlook reports!

The population of Slovenia is estimated at 2.0 million in 2009 and is slowly ageing; 16.8% of Slovenians are currently aged 65, compared to 14.1% in 2000. Slovenia is one of the richest CEE countries and successfully joined the EU in May 2004. It became the first new member state to adopt the Euro in January 2007.

Funding for healthcare in Slovenia is primarily through compulsory health insurance. The system was introduced in 1992 and is managed by the Health Insurance Institute of Slovenia. Sources of income for the fund include employers and employees, farmers, the pension fund and the state budget. Those insured are entitled to free health services, sick pay and reimbursement of travel expenses linked to obtaining health services.

In 2009, the Slovenian market for pharmaceuticals is estimated at US$1,505 million, or US$749 per capita. It is expected that the market will continue to expand at a rate of 8.6% per annum, reaching US$2,277 million, equal to US$1,138 per capita, by 2014. Around 38% of the pharmaceutical market is supplied by imports. Germany and Austria were the leading suppliers in 2008, accounting for 43.4% of imports. The value of imports has increased every year since 1999. However, there was a fall of -6.0% in 2007.

Slovenia is home to Krka and Lek, the two largest generics companies in Central and Eastern Europe. Lek has been owned by Novartis since 2002. In 2006, these companies recorded total sales of US$1,639 million. However, only 10.7% of these sales were domestic. Both companies export a large proportion of their products to Central and Eastern Europe. Lek has also strengthened its position in the US market by launching its omeprazole product, which had previously been available only in its traditional European markets.

Highly detailed report content

MARKET OUTLOOK
Key national data projections

Pharmaceutical Market Analysis
Current market size
Market structure
Unique 5-year market projections
Imports
Domestic manufacturing
Exports
Research & development

Pharmaceutical regulatory analysis
Including regulation, pricing & reimbursement and intellectual property

Pharmaceutical distribution

Healthcare analysis
Including demographics, healthcare system, health expenditure, healthcare infrastructure and personnel HEALTHCARE DATA
A comprehensive tabula review of the market, including economic indicators, demographics, health expenditure, hospital and primary care data, and healthcare personnel.

Content

GEOGRAPHY
POLITICAL OVERVIEW
ECONOMIC OVERVIEW
    Economic Indicators, 1995-2012
POPULATION
    Population as of 31st December, 1995-2007
    Population by Region, 2000-2006 (As of 31st December)
    Population by Region and Age Group, 31st December 2006
    Population by Age Group, 2000-2006 (%)
DEMOGRAPHIC INDICATORS
    Principal Demographic Indicators, 1997-2005
MORTALITY
    Causes of Death, 2001-2005
MORBIDITY
    Reported Infectious Diseases, 2000-2005
    HIV/AIDS
    Reported Cases of HIV/AIDS, 1999-2005
ORGANISATION & ADMINISTRATION
HEALTH EXPENDITURE
    Public Health Expenditure, 1997-2002 (SIT millions)
HOSPITAL SERVICES
    Hospitals & Beds 1997-2005
    Hospital Activity
    Hospital Activity, 1997-2005
AMBULATORY CARE
    Clinics
    Outpatient Facilities, 1995-1997
    Outpatient Visits to Primary Care Facilities by Cause, 2001-2004
    Dental Services
    Dental Visits, 2004
    Number of Dental Treatments by Type, 2001-2004
    Hospital Outpatient Care
    Hospital Outpatient Visits, 1999-2005
MEDICAL PERSONNEL
    Total Medical Personnel, 2000-2004
    Medical Personnel by Workplace, 2004
INTRODUCTION
REGULATORY ENVIRONMENT
    Pharmaceutical Registration
    Advertising
    Patent Protection & Intellectual Property Rights
    Pricing and Reimbursement
    Pricing
    Reimbursement
DISTRIBUTION CHANNELS
    Distributors
    Kemofarmacija d.d.
TRADE FAIRS
    Medilab
DOMESTIC PRODUCTION
    Domestic Producers
    Bayer Pharma
    Krka
    Krka Financial Results, 1998-2006 (SIT millions)
    Lek
    Lek Financial Results, 1997-2004 (SIT millions)
DIRECTORY
    Government Organisations
    Trade Associations
CHARTS
    Map of Slovenia
    Population by Age Group, 2006 (%)
    Birth and Death Rates, 1996-2005
    Causes of Death, 2005 (%)
    Public Expenditure by Type, 2002 (%)
SLOVENIA
BACKGROUND DATA
GEOGRAPHY
POLITICAL OVERVIEW
ECONOMIC OVERVIEW
    Economic Indicators, 1995-2012
POPULATION
    Population as of 31st December, 1995-2007
    Population by Region, 2000-2006 (As of 31st December)
    Population by Region and Age Group, 31st December 2006
    Population by Age Group, 2000-2006 (%)
DEMOGRAPHIC INDICATORS
    Principal Demographic Indicators, 1997-2005
MORTALITY
    Causes of Death, 2001-2005
MORBIDITY
    Reported Infectious Diseases, 2000-2005
    HIV/AIDS
    Reported Cases of HIV/AIDS, 1999-2005
CHARTS
    Map of Slovenia
    Population by Age Group, 2006 (%)
    Birth and Death Rates, 1996-2005
    Causes of Death, 2005 (%)
SLOVENIA
HEALTHCARE SYSTEM
ORGANISATION & ADMINISTRATION
HEALTH EXPENDITURE
    Public Health Expenditure, 1997-2002 (SIT millions)
HOSPITAL SERVICES
    Hospitals & Beds 1997-2005
Hospital Activity
    Hospital Activity, 1997-2005
AMBULATORY CARE
Clinics
    Outpatient Facilities, 1995-1997
    Outpatient Visits to Primary Care Facilities by Cause, 2001-2004
    Dental Services
    Dental Visits, 2004
    Number of Dental Treatments by Type, 2001-2004
Hospital Outpatient Care
    Hospital Outpatient Visits, 1999-2005
MEDICAL PERSONNEL
    Total Medical Personnel, 2000-2004
    Medical Personnel by Workplace, 2004
CHARTS
    Public Expenditure by Type, 2002 (%)
SLOVENIA
ACCESSING THE PHARMACEUTICAL MARKET
INTRODUCTION
REGULATORY ENVIRONMENT
Pharmaceutical Registration
Advertising
Patent Protection & Intellectual Property Rights
Pricing and Reimbursement
    Pricing
    Reimbursement
DISTRIBUTION CHANNELS
Distributors
    Kemofarmacija d.d.
TRADE FAIRS
Medilab
DOMESTIC PRODUCTION
Domestic Producers
    Bayer Pharma
    Krka
    Krka Financial Results, 1998-2006 (SIT millions)
    Lek
    Lek Financial Results, 1997-2004 (SIT millions)
DIRECTORY
Government Organisations
Trade Associations